NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|743523121|ref|WP_039040395|]
View 

MULTISPECIES: NAD(P)H-dependent oxidoreductase [Aeromonas]

Protein Classification

NADPH-dependent FMN reductase family protein( domain architecture ID 325)

NADPH-dependent FMN reductase family protein contains a flavodoxin-like fold, which is characterized by an open twisted/alpha beta structure consisting of five parallel beta-sheets connected by alpha-helices which surround the sheet

CATH:  3.40.50.360
Gene Ontology:  GO:0010181
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
FMN_red super family cl00438
NADPH-dependent FMN reductase;
3-172 2.03e-74

NADPH-dependent FMN reductase;


The actual alignment was detected with superfamily member PRK04930:

Pssm-ID: 469770 [Multi-domain]  Cd Length: 184  Bit Score: 222.19  E-value: 2.03e-74
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   3 RILVIFSHPALQSSRANKQLLHAIEGLEGITLHDLYQRYPDMFINVKREQALLAEHDIIVFQHPFYWYSCPAIMKEWMDL 82
Cdd:PRK04930   7 KVLLLYAHPESQDSVANRVLLKPAQQLEHVTVHDLYAHYPDFFIDIPHEQALLREHDVIVFQHPLYTYSCPALLKEWLDR 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  83 VLEYGYAYGPEAHALNGKQWLSAITTGGGPESYCRAGYNQRPLLDFLLPFQQTAQLCGMRWLPPFVLHSFHKLeDPEALR 162
Cdd:PRK04930  87 VLSRGFASGPGGNALAGKYWRSVITTGEPESAYRYDGYNRYPMSDILRPFELTAAMCRMHWLSPIIIYWARRQ-SPEELA 165
                        170
                 ....*....|
gi 743523121 163 RCGQDYRQLL 172
Cdd:PRK04930 166 SHARAYGDWL 175
 
Name Accession Description Interval E-value
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
3-172 2.03e-74

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 222.19  E-value: 2.03e-74
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   3 RILVIFSHPALQSSRANKQLLHAIEGLEGITLHDLYQRYPDMFINVKREQALLAEHDIIVFQHPFYWYSCPAIMKEWMDL 82
Cdd:PRK04930   7 KVLLLYAHPESQDSVANRVLLKPAQQLEHVTVHDLYAHYPDFFIDIPHEQALLREHDVIVFQHPLYTYSCPALLKEWLDR 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  83 VLEYGYAYGPEAHALNGKQWLSAITTGGGPESYCRAGYNQRPLLDFLLPFQQTAQLCGMRWLPPFVLHSFHKLeDPEALR 162
Cdd:PRK04930  87 VLSRGFASGPGGNALAGKYWRSVITTGEPESAYRYDGYNRYPMSDILRPFELTAAMCRMHWLSPIIIYWARRQ-SPEELA 165
                        170
                 ....*....|
gi 743523121 163 RCGQDYRQLL 172
Cdd:PRK04930 166 SHARAYGDWL 175
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
3-176 1.43e-60

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 186.97  E-value: 1.43e-60
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   3 RILVIFSHPAlqSSRANKQLLHAI-EGLE----GITLHDLYQ-------------RYPDMFINVKREQALLAEHDIIVFQ 64
Cdd:COG2249    1 KILIIYAHPD--PSSFNAALAEAAaEGLEaaghEVTVHDLYAegfdpvlsaadfyRDGPLPIDVAAEQELLLWADHLVFQ 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  65 HPFYWYSCPAIMKEWMDLVLEYGYAYGPEA----HALNGKQWLSAITTGGGPESYCRAGYNqRPLLDFLlpFQQTAQLCG 140
Cdd:COG2249   79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGgypgGLLKGKKALLVVTTGGPEEAYSRLGYG-GPIEELL--FRGTLGYCG 155
                        170       180       190
                 ....*....|....*....|....*....|....*.
gi 743523121 141 MRWLPPFVLHSFHKLeDPEALRRCGQDYRQLLCALR 176
Cdd:COG2249  156 MKVLPPFVLYGVDRS-SDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-172 1.19e-55

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 174.83  E-value: 1.19e-55
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121    2 KRILVIFSHPALQS--SRANKQLLHAIEGLEG-ITLHDLYQ--------------RYPDMFINVKREQALLAEHDIIVFQ 64
Cdd:pfam02525   1 MKILIINAHPRPGSfsSRLADALVEALKAAGHeVTVRDLYAlflpvldaedladlTYPQGAADVESEQEELLAADVIVFQ 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   65 HPFYWYSCPAIMKEWMDLVLEYGYAY-----GPEAHALNGKQWLSAITTGGGPESYCRAGYNQRPLLDFLLPFQQTAQLC 139
Cdd:pfam02525  81 FPLYWFSVPALLKGWIDRVLRAGFAFkyeegGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNGFSLDELLPYLRGILGFC 160
                         170       180       190
                  ....*....|....*....|....*....|...
gi 743523121  140 GMRWLPPFVLHSFHKLEDPEALRRCGQDYRQLL 172
Cdd:pfam02525 161 GITDLPPFAVEGTAGPEDEAALAEALERYEERL 193
 
Name Accession Description Interval E-value
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
3-172 2.03e-74

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 222.19  E-value: 2.03e-74
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   3 RILVIFSHPALQSSRANKQLLHAIEGLEGITLHDLYQRYPDMFINVKREQALLAEHDIIVFQHPFYWYSCPAIMKEWMDL 82
Cdd:PRK04930   7 KVLLLYAHPESQDSVANRVLLKPAQQLEHVTVHDLYAHYPDFFIDIPHEQALLREHDVIVFQHPLYTYSCPALLKEWLDR 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  83 VLEYGYAYGPEAHALNGKQWLSAITTGGGPESYCRAGYNQRPLLDFLLPFQQTAQLCGMRWLPPFVLHSFHKLeDPEALR 162
Cdd:PRK04930  87 VLSRGFASGPGGNALAGKYWRSVITTGEPESAYRYDGYNRYPMSDILRPFELTAAMCRMHWLSPIIIYWARRQ-SPEELA 165
                        170
                 ....*....|
gi 743523121 163 RCGQDYRQLL 172
Cdd:PRK04930 166 SHARAYGDWL 175
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
3-176 1.43e-60

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 186.97  E-value: 1.43e-60
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   3 RILVIFSHPAlqSSRANKQLLHAI-EGLE----GITLHDLYQ-------------RYPDMFINVKREQALLAEHDIIVFQ 64
Cdd:COG2249    1 KILIIYAHPD--PSSFNAALAEAAaEGLEaaghEVTVHDLYAegfdpvlsaadfyRDGPLPIDVAAEQELLLWADHLVFQ 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  65 HPFYWYSCPAIMKEWMDLVLEYGYAYGPEA----HALNGKQWLSAITTGGGPESYCRAGYNqRPLLDFLlpFQQTAQLCG 140
Cdd:COG2249   79 FPLWWYSMPALLKGWIDRVLTPGFAYGYGGgypgGLLKGKKALLVVTTGGPEEAYSRLGYG-GPIEELL--FRGTLGYCG 155
                        170       180       190
                 ....*....|....*....|....*....|....*.
gi 743523121 141 MRWLPPFVLHSFHKLeDPEALRRCGQDYRQLLCALR 176
Cdd:COG2249  156 MKVLPPFVLYGVDRS-SDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
2-172 1.19e-55

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 174.83  E-value: 1.19e-55
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121    2 KRILVIFSHPALQS--SRANKQLLHAIEGLEG-ITLHDLYQ--------------RYPDMFINVKREQALLAEHDIIVFQ 64
Cdd:pfam02525   1 MKILIINAHPRPGSfsSRLADALVEALKAAGHeVTVRDLYAlflpvldaedladlTYPQGAADVESEQEELLAADVIVFQ 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   65 HPFYWYSCPAIMKEWMDLVLEYGYAY-----GPEAHALNGKQWLSAITTGGGPESYCRAGYNQRPLLDFLLPFQQTAQLC 139
Cdd:pfam02525  81 FPLYWFSVPALLKGWIDRVLRAGFAFkyeegGPGGGGLLGKKVLVIVTTGGPEYAYGKGGYNGFSLDELLPYLRGILGFC 160
                         170       180       190
                  ....*....|....*....|....*....|...
gi 743523121  140 GMRWLPPFVLHSFHKLEDPEALRRCGQDYRQLL 172
Cdd:pfam02525 161 GITDLPPFAVEGTAGPEDEAALAEALERYEERL 193
PRK00871 PRK00871
glutathione-regulated potassium-efflux system oxidoreductase KefF;
4-172 5.34e-47

glutathione-regulated potassium-efflux system oxidoreductase KefF;


Pssm-ID: 234852  Cd Length: 176  Bit Score: 152.25  E-value: 5.34e-47
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   4 ILVIFSHPALQSSRANKQLLHAIEGLEGITLHDLYQRYPDMFINVKREQALLAEHDIIVFQHPFYWYSCPAIMKEWMDLV 83
Cdd:PRK00871   2 ILIIYAHPYPHHSHANKRMLEQARTLEGVEIRSLYQLYPDFNIDIAAEQEALSRADLIVWQHPMQWYSIPPLLKLWIDKV 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  84 LEYGYAYGPEAHALNGKQWLSAITTGGGPESYCRAGYNQRPLLDflLPFQQTAQLCGMRWLPPFVLHSFHKLEDpEALRR 163
Cdd:PRK00871  82 LSHGWAYGHGGTALHGKHLLWAVTTGGGESHFEIGAHPGFDVLS--QPLQATALYCGLNWLPPFAMHCTFICDD-ETLEG 158

                 ....*....
gi 743523121 164 CGQDYRQLL 172
Cdd:PRK00871 159 QARHYKQRL 167
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-122 4.37e-12

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 62.03  E-value: 4.37e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   1 MKRILVIFSHPALQSSRAnKQLLHAIEGLE----GITLHDLY--------------------QRYPDmfiNVKREQALLA 56
Cdd:PRK09739   3 SMRIYLVWAHPRHDSLTA-KVAEAIHQRAQerghQVEELDLYrsgfdpvltpedepdwknpdKRYSP---EVHQLYSELL 78
                         90       100       110       120       130       140
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 743523121  57 EHDIIVFQHPFYWYSCPAIMKEWMDLVLEYGYAYGpEAHALNGKQ--WLSAIttGGGPESYCRAGYNQ 122
Cdd:PRK09739  79 EHDALVFVFPLWWYSFPAMLKGYIDRVWNNGLAYG-DGHKLPFNKvrWVALV--GGSKESFVKRGWEK 143
WrbA COG0655
Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and ...
55-164 4.89e-05

Multimeric flavodoxin WrbA, includes NAD(P)H:quinone oxidoreductase [Energy production and conversion];


Pssm-ID: 440420 [Multi-domain]  Cd Length: 181  Bit Score: 42.22  E-value: 4.89e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  55 LAEHDIIVFQHPFYWYSCPAIMKEWMDLVleygYAYGPEAHALNGKQwLSAITTGGGpesycraGYNQRPLLDFLLPFQQ 134
Cdd:COG0655   68 LLEADGIIFGSPTYFGNMSAQLKAFIDRL----YALWAKGKLLKGKV-GAVFTTGGH-------GGAEATLLSLNTFLLH 135
                         90       100       110
                 ....*....|....*....|....*....|....*
gi 743523121 135 taqlCGMRWLP-PFVLHSFH----KLEDPEALRRC 164
Cdd:COG0655  136 ----HGMIVVGlPPYGAVGGggpgDVLDEEGLATA 166
FMN_red pfam03358
NADPH-dependent FMN reductase;
3-129 5.88e-05

NADPH-dependent FMN reductase;


Pssm-ID: 427259 [Multi-domain]  Cd Length: 152  Bit Score: 41.46  E-value: 5.88e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121    3 RILVIFSHPALQSSraNKQLL-----HAIEGLEG--ITLHDL-----------YQRYPDMFINVKReqaLLAEHDIIVFQ 64
Cdd:pfam03358   2 KILAISGSPRKGSN--TRKLArwaaeLLEEGAEVelIDLADLilplcdedleeEQGDPDDVQELRE---KIAAADAIIIV 76
                          90       100       110       120       130       140
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 743523121   65 HPFYWYSCPAIMKEWMDLVleyGYAYGPeaHALNGKQwLSAITTGGGPESYCRAGYNQRPLLDFL 129
Cdd:pfam03358  77 TPEYNGSVSGLLKNAIDWL---SRLRGG--KELRGKP-VAIVSTGGGRSGGLRAVEQLRQVLAEL 135
AzoR COG1182
FMN-dependent NADH-azoreductase [Energy production and conversion];
1-132 3.82e-04

FMN-dependent NADH-azoreductase [Energy production and conversion];


Pssm-ID: 440795 [Multi-domain]  Cd Length: 205  Bit Score: 39.73  E-value: 3.82e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   1 MKRILVIFSHPALQSSRANK-------QLLHAIEGLEgITLHDLY--------------------QRYPDMFINVKREQA 53
Cdd:COG1182    1 MMKLLHIDSSPRGEGSVSRRladafvaALRAAHPDDE-VTYRDLAaeplphldgawlaafftpaeGRTPEQQAALALSDE 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121  54 LLAE---HDIIVFQHPFYWYSCPAIMKEWMDLVLEYGY-----AYGPEaHALNGKQWLSAITTGGGPESYCRAGYN-QRP 124
Cdd:COG1182   80 LIDEllaADVIVIGAPMYNFGIPSQLKAWIDHIARAGRtfrytENGPV-GLLTGKKAVVITARGGVYSGGPAAGMDfQTP 158

                 ....*...
gi 743523121 125 LLDFLLPF 132
Cdd:COG1182  159 YLRTVLGF 166
PRK00170 PRK00170
azoreductase; Reviewed
1-111 8.60e-03

azoreductase; Reviewed


Pssm-ID: 234675 [Multi-domain]  Cd Length: 201  Bit Score: 35.64  E-value: 8.60e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 743523121   1 MKRILVIFSHPALQSSRANKQLLHAIE-------GLEgITLHDLYQRYPDMFIN--------------------VKREQA 53
Cdd:PRK00170   1 MSKVLVIKSSILGDYSQSMQLGDAFIEaykeahpDDE-VTVRDLAAEPIPVLDGevvgalgksaetltprqqeaVALSDE 79
                         90       100       110       120       130       140
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 743523121  54 LLAE---HDIIVFQHPFYWYSCPAIMKEWMDLVLEYG--YAY---GPEAhALNGKQWLsAITTGGG 111
Cdd:PRK00170  80 LLEEflaADKIVIAAPMYNFSIPTQLKAYIDLIARAGktFRYtenGPVG-LVTGKKAL-LITSRGG 143
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH